The Handbook of Contemporary Neuropharmacology is an invaluable resource for principal investigators and working scientists in academia, government and industry. Provides a readily accessible reference for students, professionals and libraries alike. Editors are recognized authorities in the neuropharmacology and science field. Comprehensive reference text for active junior and senior neurobiologists. Fills an important niche as a text between research publications and clinical applications.

Table of Contents

• SOUP OR SPARKS: THE HISTORY OF DRUGS AND SYNAPSES
• SYNAPTIC TRANSMISSION: INTERCELLULAR SIGNALING
• SYNAPTIC TRANSMISSION: INTRACELLULAR SIGNALING
• NEURONAL NICOTINIC RECEPTORS: ONE HUNDRED YEARS OF PROGRESS
• MUSCARINIC ACETYLCHOLINE RECEPTORS
• NOREPINEPHRINE/EPINEPHRINE
• DOPAMINERGIC NEUROTRANSMISSION*
• SEROTONIN SYSTEMS
• NEUROPHARMACOLOGY OF HISTAMINE IN BRAIN
• IONOTROPIC GLUTAMATE RECEPTORS
• METABOTROPIC GLUTAMATE RECEPTORS
• PHARMACOLOGY OF THE GABAA RECEPTOR
• METABOTROPIC GABA RECEPTORS
• VOLTAGE-GATED ION CHANNELS
• NEUROPEPTIDES
• NEUROTRANSMITTER TRANSPORTERS
• GASEOUS SIGNALING: NITRIC OXIDE AND CARBON MONOXIDE AS MESSENGER MOLECULES
• NEUROBIOLOGY AND TREATMENT OF DEPRESSION
• NEUROTROPHIC FACTORS IN ETIOLOGY AND TREATMENT OF MOOD DISORDERS
• ANTIDEPRESSANT TREATMENT AND HIPPOCAMPAL NEUROGENESIS: MONOAMINE AND STRESS HYPOTHESES OF DEPRESSION CONVERGE
• NEUROENDOCRINE ABNORMALITIES IN WOMEN WITH DEPRESSION LINKED TO THE REPRODUCTIVE CYCLE
• NEUROBIOLOGY AND PHARMACOTHERAPY OF BIPOLAR DISORDER
• NEUROBIOLOGY OF ANXIETY
• PHARMACOTHERAPY OF ANXIETY
• BENZODIAZEPINES
• NEUROACTIVE STEROIDS IN ANXIETY AND STRESS
• EMERGING ANXIOLYTICS: CORTICOTROPIN-RELEASING FACTOR RECEPTOR ANTAGONISTS
• NEUROBIOLOGY AND PHARMACOTHERAPY OF OBSESSIVE-COMPULSIVE DISORDER
• PHENOMENOLOGY AND CLINICAL SCIENCE OF SCHIZOPHRENIA
• DOPAMINE AND GLUTAMATE HYPOTHESES OF SCHIZOPHRENIA
• MOLECULAR GENETICS OF SCHIZOPHRENIA
• POSTMORTEM BRAIN STUDIES: FOCUS ON SUSCEPTIBILITY GENES IN SCHIZOPHRENIA
• PHARMACOTHERAPY OF SCHIZOPHRENIA
• ATYPICAL ANTIPSYCHOTIC DRUGS: MECHANISM OF ACTION
• INTRODUCTION TO ADDICTIVE DISORDERS: IMPLICATIONS FOR PHARMACOTHERAPIES
• DOPAMINERGIC AND GABAERGIC REGULATION OF ALCOHOL-MOTIVATED BEHAVIORS: NOVEL NEUROANATOMICAL SUBSTRATES
• NICOTINE
• PSYCHOSTIMULANTS
• MDMA AND OTHER “CLUB DRUGS”
• MARIJUANA: PHARMACOLOGY AND INTERACTION WITH THE ENDOCANNABINOID SYSTEM
• OPIATES AND ADDICTION
• NEURONAL PATHWAYS FOR PAIN PROCESSING
• VANILLOID RECEPTOR PATHWAYS
• OPIOID RECEPTORS
• ADVENT OF A NEW GENERATION OF ANTIMIGRAINE MEDICATIONS
• FUNCTION AND PHARMACOLOGY OF CIRCADIAN CLOCKS
• MELATONIN RECEPTORS IN CENTRAL NERVOUS SYSTEM
• NARCOLEPSY: NEUROPHARMACOLOGICAL ASPECTS
• HYPOCRETIN/OREXIN SYSTEM
• PROKINETICINS: NEW PAIR OF REGULATORY PEPTIDES
• SEDATIVES AND HYPNOTICS
• REGULATION OF ADULT NEUROGENESIS
• NEUROTROPHIC FACTORS
• NEUROTROPHINS AND THEIR RECEPTORS
• TOURETTE'S SYNDROME AND PHARMACOTHERAPY
• NEUROPHARMACOLOGY OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
• PSYCHOPHARMACOLOGY OF AUTISM SPECTRUM DISORDERS
• STROKE: MECHANISMS OF EXCITOTOXICITY AND APPROACHES FOR THERAPY
• EPILEPSY: MECHANISMS OF DRUG ACTION AND CLINICAL TREATMENT
• PHARMACOTHERAPY FOR TRAUMATIC BRAIN INJURY
• DEMENTIA AND PHARMACOTHERAPY: MEMORY DRUGS
• PHARMACOTHERAPY AND TREATMENT OF PARKINSON’S DISEASE
• PARKINSON’S DISEASE: GENETICS AND PATHOGENESIS
• INVERTEBRATES AS POWERFUL GENETIC MODELS FOR HUMAN NEURODEGENERATIVE DISEASES
• MYELIN LIPIDS AND PROTEINS: STRUCTURE, FUNCTION, AND ROLES IN NEUROLOGICAL DISORDERS
• PHARMACOLOGY OF INFLAMMATION
• PHARMACOLOGICAL TREATMENT OF MULTIPLE SCLEROSIS
• NOVEL THERAPIES FOR MULTIPLE SCLEROSIS
• NEUROPHARMACOLOGY OF HIV/AIDS
• LEPTIN: A METABOLIC PERSPECTIVE
• GHRELIN: STRUCTURAL AND FUNCTIONAL PROPERTIES
• MECHANISMS CONTROLLING ADIPOSE TISSUE METABOLISM BY THE SYMPATHETIC NERVOUS SYSTEM: ANATOMICAL AND MOLECULAR ASPECTS
• ANTIOBESITY PHARMACOTHERAPY: CURRENT TREATMENT OPTIONS AND FUTURE PERSPECTIVES